Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, MiRNA-based therapy for Pulmonary Hypertension: MiRNA-153 inhibits the development of pulmonary hypertension via down regulation of its target genes, 19/January/2015, 12.22 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests, for the first time, that MiRNA-153, by increasing the expression of its target genes, it may inhibit pulmonary hypertension. Thus, pharmacological formulations encompassing “MiRNA-153 or its activators” may be used to treat pulmonary hypertension.
Amount: $ 500
Undisclosed information: How MiRNA-153 inhibits the development of pulmonary hypertension
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
